Carcinogen-specific induction of genetic instability
A Bardelli1, D P Cahill, G Lederer
1The Johns Hopkins Oncology Center, Howard Hughes Medical Institute, and Graduate Program in Human Genetics and Molecular Biology, 1650 Orleans Street, Baltimore, MD 21231, USA.
Specific carcinogens select for distinct cancer genetic instabilities. Cells resistant to the bulky-adduct agent PhIP showed chromosomal instability (CIN), while those resistant to the methylating agent MNNG showed microsatellite instability (MIN).
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Cancer cells exhibit various forms of genetic instability.
- The relationship between carcinogen exposure and specific instability types is under investigation.
Purpose of the Study:
- To test the hypothesis that carcinogen exposure selects for distinct genetic instability phenotypes in cancer cells.
- To investigate the reciprocal relationship between carcinogen resistance and genetic instability.
Main Methods:
- Treatment of immortal human cells with representative carcinogens: 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
- Assessment of genetic instability types: chromosomal instability (CIN) and microsatellite instability (MIN) associated with mismatch repair defects.
- Experimental induction of CIN and MIN phenotypes to test for carcinogen resistance.
Main Results:
- Cells resistant to PhIP (bulky-adduct agent) developed CIN.
- Cells resistant to MNNG (methylating agent) developed MIN.
- Induced CIN cells showed resistance to PhIP, and induced MIN cells showed resistance to MNNG.
Conclusions:
- Specific carcinogens can select for tumor cells with distinct genetic instability profiles.
- The type of genetic instability in cancer cells can reflect the selective pressures of specific carcinogens.
- A reciprocal relationship exists between carcinogen exposure and the development of specific genetic instabilities.
More Related Videos
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
04:12Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)
Published on: December 19, 2019
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Cancers Originate from Somatic Mutations in a Single Cell
Cancer Prevention
Some...
Induced Pluripotent Stem Cells
Somatic cells are...
Mutagenicity and Carcinogenicity
Spontaneous and Induced Mutations
